AAA has completed a capital increase of €23 million (approx. $26 million), led by Adage Capital Management, LP (Adage). Alongside Adage as new investors in AAA are certain funds and accounts managed by T. Rowe Price Associates, Inc., and Rock Springs Capital Management LP.
Stefano Buono, Chief Executive Officer of AAA commented: “We are very pleased to have completed this pivotal capital increase, with the support of a strategic group of top US healthcare investors. This financing is a critical milestone for us, as we prepare for the Phase III trial results for Lutathera, and the continued progress of our Molecular Nuclear Medicine pipeline.”